← All peptidesGLP-1 / Metabolic
Semaglutide
Semaglutide (Ozempic, Wegovy)
Long-acting GLP-1 receptor agonist. Appetite suppression, glycemic control, weight loss.
Typical dose
0.25–2.4 mg
Frequency
Once weekly
Half-life
168 h
Route
subcutaneous
Typical vial sizes
2 mg4 mg5 mg10 mg
Sample reconstitution
2 mg vial · 2 mL bac water · 1.325 mg dose
- Draw volume
- 1.325 mL
- Insulin units
- 133 units
- Concentration
- 1.00 mg/mL
- Doses per vial
- 1.5
Research notes
Standard titration: 0.25 → 0.5 → 1.0 → 1.7 → 2.4mg over 16+ weeks.
Research use only.
Information on this page is a reference log compiled from public sources and is not medical advice. Consult a licensed physician before making any decisions about your health.